Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Freshpet (FRPT) Cash & Equivalents (2016 - 2025)

Freshpet's Cash & Equivalents history spans 13 years, with the latest figure at $278.0 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 3.48% year-over-year to $278.0 million; the TTM value through Dec 2025 reached $278.0 million, up 3.48%, while the annual FY2025 figure was $278.0 million, 3.48% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $278.0 million at Freshpet, up from $274.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $341.0 million in Q1 2021 and bottomed at $29.7 million in Q1 2022.
  • The 5-year median for Cash & Equivalents is $263.3 million (2024), against an average of $244.2 million.
  • The largest annual shift saw Cash & Equivalents tumbled 91.28% in 2022 before it surged 1034.02% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $72.8 million in 2021, then soared by 82.36% to $132.7 million in 2022, then skyrocketed by 123.66% to $296.9 million in 2023, then dropped by 9.51% to $268.6 million in 2024, then increased by 3.48% to $278.0 million in 2025.
  • Per Business Quant, the three most recent readings for FRPT's Cash & Equivalents are $278.0 million (Q4 2025), $274.6 million (Q3 2025), and $243.7 million (Q2 2025).